-
With Post-Brexit Move to Amsterdam Complete, EMA Renews Rare Disease Focus
In an exclusive interview, Violeta Stoyanova, MD, chair of the Committee on Orphan Medicinal Products, discusses the EMA’s renewed focus on rare diseases. Click here to find out what Dr. Stoyanova had to say.
What did you think of this interview?
Sorry, there were no replies found.
Log in to reply.